Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.
Bilici A, Uysal M, Menekse S, Akin S, Yildiz F, Turan M, Sezgin Goksu S, Beypinar I, Sakalar T, Değirmenci M, Erdem D, Basaran G, Olmez OF, Avci N, Tural D, Sakin A, Turker S, Demir A, Temiz S, Kaplan MA, Dogan M, Tanriverdi O, Bilgetekin I, Cinkir HY, Acikgoz O, Paydas S, Uslu R, Turhal S. Bilici A, et al. Among authors: kaplan ma. Cancer Invest. 2022 Feb;40(2):199-209. doi: 10.1080/07357907.2021.2017952. Epub 2021 Dec 22. Cancer Invest. 2022. PMID: 34894960
Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.
Kefeli U, Buyuberber S, Akyol M, Yildiz R, Kaplan MA, Ciltas A, Sevinc A, Karaca H, Seker M, Ozdemir N, Alacacioglu A, Coskun U, Isikdogan A, Dane F, Gumus M, Ozkan M, Suner A, Tarhan MO, Benekli M. Kefeli U, et al. Among authors: kaplan ma. Hepatogastroenterology. 2013 Jun;60(124):647-52. doi: 10.5754/hge12692. Hepatogastroenterology. 2013. PMID: 23165189
IPS-3 Validation in 1012 cases with classical hodgkin lymphoma.
Paydas S, Laçin S, Doğan M, Barista I, Yildiz B, Seydaoglu G, Karadurmus N, Civriz S, Kaplan MA, Yagci M, Gurkan E, Ercolak V. Paydas S, et al. Among authors: kaplan ma. Leuk Res. 2021 Mar;102:106519. doi: 10.1016/j.leukres.2021.106519. Epub 2021 Jan 29. Leuk Res. 2021. PMID: 33556744
Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma.
Paydas S, Lacin S, Dogan M, Barista I, Yildiz B, Seydaoglu G, Karadurmus N, Civriz S, Kaplan MA, Yagci M, Dincyurek HD, Ercolak V. Paydas S, et al. Among authors: kaplan ma. Leuk Res. 2021 Aug;107:106586. doi: 10.1016/j.leukres.2021.106586. Epub 2021 Apr 24. Leuk Res. 2021. PMID: 34082249
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Bilici A, Koca S, Karaagac M, Aydin SG, Eraslan E, Kaplan MA, Ocak B, Goksu SS, Paydas S, Akgul F, Derin S, Ergun Y, Yekeduz E, Erol C, Ozyukseler DT, Demiray AG, Karaca M, Guc ZG, Menekse S, Cinkir HY, Gumusay O, Sakin A, Ozkul O, Demir H, Erdem D, Besiroglu M, Unal OU, Acar R, Koral L, Sahin S, Sakalar T, Bahceci A, Ozveren A, Gunaydin UM, Seker MM, Sunar V, Dal P, Artac M, Turhal S. Bilici A, et al. Among authors: kaplan ma. J Cancer Res Clin Oncol. 2023 Sep;149(11):8243-8253. doi: 10.1007/s00432-023-04766-3. Epub 2023 Apr 17. J Cancer Res Clin Oncol. 2023. PMID: 37067546
453 results